Academic literature on the topic 'Incontinence urinaire – thérapie'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Incontinence urinaire – thérapie.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Incontinence urinaire – thérapie":
Boissier, R., and G. Karsenty. "Thérapie cellulaire et incontinence urinaire." Progrès en Urologie 22, no. 8 (July 2012): 454–61. http://dx.doi.org/10.1016/j.purol.2012.04.008.
Karsenty, G. "Thérapie cellulaire et incontinence urinaire : si loin, si proche." Progrès en Urologie 21, no. 12 (November 2011): 835–36. http://dx.doi.org/10.1016/j.purol.2011.03.004.
Abdou, A., J. N. Cornu, P. Sèbe, C. Ciofu, L. Peyrat, O. Cussenot, and F. Haab. "Thérapie de sauvetage par implantation d’un sphincter artificiel urinaire après échec de bandelette Advance™ pour incontinence urinaire après prostatectomie : une expérience monocentrique." Progrès en Urologie 22, no. 11 (October 2012): 650–56. http://dx.doi.org/10.1016/j.purol.2012.06.011.
Fourmarier, M., A. de la Taille, A. R. Azzouzi, C. Ballereau, F. Desgranchamps, M. Devonec, O. Haillot, B. Lukacs, E. Castel, and C. Saussine. "Prise en charge d’une incontinence urinaire masculine après prostatectomie radicale (CTMH AFU 2006 – 4/5) : place de l’injection intra-urétrale de macroplastique, du sphincter urinaire artificiel et des thérapies cellulaires." Progrès en Urologie 18, no. 2 (February 2008): 85–88. http://dx.doi.org/10.1016/j.purol.2007.10.011.
Dissertations / Theses on the topic "Incontinence urinaire – thérapie":
Zini, Laurent. "La thérapie cellulaire de l'insuffisance sphinctérienne urétrale : description d’un modèle animal préclinique et comparaison de 3 techniques de tranferts de cellules précurseurs musculaires." Paris 12, 2007. http://www.theses.fr/2007PA120027.
We consider a treatment of urethral sphincter insufficiency based on transplantation of muscle precursor cells (MPC). The aim of this project was to restor a physiological urethral tonicity. The pig model by electrocautery sphincter injury provokes irreversible damage to the myofibers and their nerve endings leading to fibrosis and reproducing the histopathological condition of sphincter insufficiency. We compared three ways to preform transplantation of MPCs into the urethra a distance away from the SUS in the proximal urethral segment. We used conventional methods for isolating myogenic (satellite) cells with in vitro proliferation, without in vitro proliferation and a new method of transfer of MPCs by implantation of muscle strips. We investigated the changes in UPP and the innervation of graft derived myotubes. The maximal closure pressure of the proximal urethral segment was not significantly modified after MPC injection, cultured or not, due to a massive cell death after injection. After muscle strips implantation, a distinct peak pressure was constantly found in the proximal urethral segment. This procedure allows the proper orientation of myotube formation in the urethra, a factor is not controlled with MPC injection. Urodynamic studies after curarization revealed that the pressure peak was under neural control. Myofiber implantation exerted a trophic effect on the urethral nervous system, resulting in the development of a dense network of nerve fibers running toward to the acetylcholine receptors of the myotubes. The origin of these nerves are currently under investigation at our laboratory. This treatment could constitute an option to the artificial urinary sphincter which is currently the gold standard of urethral sphincter insufficiency. This treatment have to be associated with physiotherapy exercise aimed to realize the formation of a new muscle
Biardeau, Xavier. "Optimisation des thérapies de stimulation/modulation électrique dans le traitement des troubles vésico-sphinctériens neurogènes et non-neurogènes." Electronic Thesis or Diss., Université de Lille (2022-....), 2024. http://www.theses.fr/2024ULILS014.
Even if it involves alternating between a filling phase and an emptying phase, the normal micturition cycle cannot be summed up as a binary operation but involves the constant consideration of multiple factors: the filling level of the bladder reservoir, the safety of the environment in which we live, the emotional context in which we evolve and the social constraints to which we are subjected.We now know that there are alterations and/or modifications in brain activity and connectivity, as well as changes in the regulation of the autonomic nervous system, in certain types of lower urinary tract dysfunction - notably in overactive bladder or urge urinary incontinence and in certain types of voiding dysfunctions. Among the therapies available today, electrical modulation/stimulation therapies (tibial neurostimulation and sacral neuromodulation) appear able to normalize and/or modify brain activity and connectivity, as well as ANS balance. They could thus provide at least a partial response to some of the etiopathogenies underlying these lower urinary tract dysfunctions. However, the deployment and positioning of these electrical modulation/stimulation therapies are still limited by an incomplete understanding of their mechanisms of action, imperfect identification of the indications and populations most likely to benefit from these therapies, a lack of consensus on the setting of the electrical current delivered, and a lack of medium and long-term evaluation. In the first part, we questioned the indications for these therapies, and particularly their place as a preventive approach for lower urinary tract dysfunctions due to spinal cord injury. We also questioned the relation, in terms of efficacy, between transcutaneous tibial neurostimulation and sacral neuromodulation, to better support patients in shared medical decision-making processe. Finally, we developed the first tool to predict the success of sacral neuromodulation as a treatment for voiding dysfunction. In the second part, we questioned the mechanisms of action, and more specifically the changes in the balance of the autonomic nervous system in response to an acute S3 sacral root stimulation.In the third part, we questioned the mid-term follow-up (5 years) after definitive implantation of sacral neuromodulation in a geographic population pool, looking for risk factors for discontinuation of follow-up. These data, although still to be supplemented by future research projects, will enable us to further optimize electrical modulation/stimulation therapies in the management of neurogenic and non-neurogenic lower urinary tract dysfunctions
Swieb, Salem. "Développement de thérapies cellulaires pour les complications urinaires et sexuelles de la prostatectomie radicale." Phd thesis, Université Paris-Est, 2008. http://tel.archives-ouvertes.fr/tel-00461672.
Bierinx, Anne-Sophie. "La cellule satellite, clé de l'efficacité des thérapies cellulaire et génique du muscle strie déficient." Paris 11, 2008. http://www.theses.fr/2008PA113004.
Satellite cells are mononucleated cells located at the periphery of the muscle fibre, between the sarcolema and the extracellular matrix. They are quiescent in adult and considered as stem cells. When they are activated, they are allowed to proliferate in order to grow muscle fibre in young or to regenerate injured fibres. In the first part of the present study, we researched how optimize the regeneration of the urethral striated sphincter as it is injured after prostatectomy leading to urinary incontinence. Up today, injections of cultivated myogenic cells result of temporary functional improvement but the fate of the injected cells remains uncertain. Furthermore myogenic cells loss their regenerative capacities when they are cultivated outside their natural environment. We tested the implantation of freshly minced muscle fragments that contain satellite cells surviving in their “cellular niche”, into the gap resulting from a partial urethral resection in male rat. 28 days after surgery, sutured rats remained fully incontinent without urethral activity since autografted rats returned to continence with micturition cycles and sphincter activity close to normal. In the second part, we have attempted to delay and/or ameliorate the course of the dystrophic muscular phenotype by inhibiting the myostatin activity. An AAV-mediated myostatin propeptide gene was injected into a hindlimb muscle of 17 old-day mdx mice before the first round of degeneration-regeneration. This treatment was ineffective on the time course of the dystrophy and on the contractile properties of the Tibialis Anterior muscle although the construct was detectable up to 8 weeks of age. Muscle growth and regeneration depending on satellite cell proliferation and fusion, we suggest that these small cells have not been transfected at the injection time. These 2 studies show the main role played by satellite cells in the treatment of muscular diseases. In the perspective of future muscular therapies, “cellular niche” preservation and conditions of in vivo satellite cell transfection cannot be ignored
Le, Berre Mélanie. "Comparaison de la force musculaire des membres inférieurs, de l’équilibre, de la mobilité et de la fonction chez les femmes âgées avec incontinence urinaire d’urgence ou mixte et les femmes âgées sans incontinence." Thèse, 2018. http://hdl.handle.net/1866/22138.
Pontbriand-Drolet, Stéphanie. "Étude comparative de la morphologie du plancher pelvien des femmes âgées continentes et avec incontinence urinaire." Thèse, 2012. http://hdl.handle.net/1866/8593.
Aims: The study’s aim was to compare: a) pelvic floor muscle (PFM), bladder neck and urethral sphincter morphologies using MRI and b) PFM function using digital palpation (PERFECT scheme) in continent women, women with stress (SUI) and mixed (MUI) urinary incontinence. Method: Women were taught how to perform PFM contractions correctly and their PFM function was assessed, then each woman completed a dynamic 3T MRI session. Results: 66 women participated in the study. Groups were similar for age, BMI, vaginal deliveries and hysterectomies. Validity and reliability of the different anatomical measures used has been confirmed at the beginning of the study. To control for the potential effect of pelvic size on study parameters, women were matched based on pelvic inlet length. MUI women seemed to have lower PFM resting position and pelvic organ support at rest, based on their M-Line, PCL/H-Line angle and urethrovesical (UV) junction height. However, SUI women seemed to have a PFM morphology similar to that of continent women, but presented a greater occurrence of bladder neck funnelling and a larger posterior UV angle. There were no differences in urethral sphincter morphology between the 3 groups. Functionally, as shown by the PERFECT scheme results, both UI groups had poorer PFM strength on MVC then continent women. The MUI group also showed poor PFM elevation on contraction. Conversely, women with SUI had a timing problem on cough. Conclusion: The deficits in women with SUI and MUI appear to be very different. Notwithstanding, they all support the rationale for PFM exercise treatment in older women with SUI and MUI. However, the findings suggest the need for rehabilitation treatments specificity for each UI type.
Martin, Claudine. "Suivi à long terme de l’efficacité d’un traitement de physiothérapie sur l'incontinence urinaire d'effort persistante en période postnatale." Thèse, 2008. http://hdl.handle.net/1866/3154.
Stress urinary incontinence is a common condition in the postpartum period affecting up to 77% of women. Nine women out of ten still suffering from SUI three months after giving birth will have symptoms of SUI five years later. Physiotherapy treatment via pelvic floor muscles strengthening exercises is recognized as an efficient first line of treatment for SUI. Although studies have shown good short term cure rates for persistent SUI, two long term follow-ups RCT’s have demonstrated that the effect was not maintained through time. The effect of an intensive and supervised physiotherapy pelvic floor strengthening program was evaluated in a previous randomized controlled trial (RCT) seven years ago. The main objective of the present study was to evaluate the effect of this program seven years after cessation of treatment. A secondary objective is to investigate the influence of four possible predictors of long term SUI symptoms and quality of life. The 57 women who completed the initial trial were contacted by telephone and invited to participate in a 7 year follow-up. Twenty-one participants underwent the clinical evaluation and answered four questionnaires while 10 participants answered only the questionnaires. The clinical evaluation included a provocative pad test and dynamometry of the pelvic floor muscles. The main outcome measure was the 20-minute modified pad test. Secondary outcomes were pelvic floor muscle strength measure by the Montreal dynamometer, symptoms of incontinence measured by the Urogenital Distress Inventory questionnaire, quality of life measured by the Incontinence Impact Questionnaire and the perceived burden of SUI measured by the Visual Analog Scale. The evaluation was completed by a questionnaire on four potential predictors of SUI: subsequent pregnancies, chronic constipation, body mass index and the frequency of pelvic floor muscle exercises. Forty-eight percent (10/21) of the participants were continent according to the pad test. The mean improvement between baseline and seven year follow-up was 26.9 g. (SD = vii 68.0g.). There was no statistically significant difference in pelvic floor muscle strength between baseline, after treatment and the follow-up (p = 0.74). The IIQ and VAS score were significantly lower at the seven year follow-up than at baseline (IIQ: 23.4 vs 15.6 , p = 0.007 and VAS: 6.7 vs 5.1, p = 0.001). The UDI scores were higher at follow-up (15.6) than baseline (11.3, p = 0.041) and after treatment (5.7, p = 0.00). Maintaining pelvic floor exercise at seven years after treatment had a strong trend towards a decrease of 5.7 g. for pad test results (p = 0.051). Limits of this study are the small sample size and the bias related to treatment seeking behavior amongst women who agreed to participate. Nevertheless, results seem to indicate that an intensive closely supervised pelvic floor training program is effective in the long run for one woman out of two. Although symptoms of SUI, as measured by the pad test and the UDI questionnaire, seem to reappear with time, quality of life is still better seven years after treatment than at baseline. Continuation of pelvic floor exercises seems to decrease the urine leakage upon exertion and thus should be encouraged even after cessation of intense training. For logistic reasons, the data collection for this research project continued after the writing of this thesis. Final results are available from Chantale Dumoulin pht, PhD, professor at the University of Montreal.
Elliott, Valérie. "L’utilisation de la réadaptation par la réalité virtuelle pour traiter l’incontinence urinaire mixte de la femme âgée : une étude de faisabilité." Thèse, 2012. http://hdl.handle.net/1866/9141.
Aims: The main objective of the study was to evaluate the feasibility of using a combination of pelvic floor muscle (PFM) training and virtual reality rehabilitation (VRR) (PFM/VRR training program) to treat mixed urinary incontinence (MUI) among older women. Feasibility was defined as the participants’ rate of participation and completion of the PFM/VRR training program and of the home exercise program. The other study objectives were to evaluate the effectiveness of the PFM/VRR program on MUI symptoms, on quality of life (QoL), on PFM function and on cognitive functions, more precisely on dual-task executive functioning. Patient satisfaction was also assessed after the intervention. The study included a qualitative component aiming to gather information regarding: (1) patient-perceived facilitators and barriers to weekly PFM/VRR class attendance and (2) patient-perceived advantages and inconveniences associated with the use of VRR as a component of conventional PFM rehabilitation. Methods: Every woman participated in two pre-intervention evaluations (pre-1 & pre-2) followed by 12 weeks of a PFM/VRR training program and one post-intervention evaluation (post). Participants were also given a 20-minute static PFM home exercise program. At the end of the twelfth class, a participant group discussion was conducted. The first two evaluations were conducted 2 weeks apart to ensure consistency in the incontinence, PFM and executive functions measures prior to the intervention. Results: 24 women participated in the study. The majority of participants complied with the study demands in terms of attendance to the weekly treatment sessions (91 %), adherence to the home exercise program (92%) and completion of the three (pre-1, pre-2 and post) evaluations (96 %). The PFM/VRR training program was effective in reducing urinary incontinence symptoms, in enhancing QoL, in improving the ability of older women with MUI to manage dual-task situations and tends to improve PFM function of these women. The participant appreciation of the VRR component was 9.8/10 and the VRR component was identified by the participants as a facilitator to their weekly class participation. Conclusion: A combined PFM/VRR is an acceptable functional training approach for older women with MUI as they are capable of complying with treatment program demands.
Paquin, Marie-Hélène. "Caractéristiques de la marche avec et sans l’envie pressante d’uriner chez la femme âgée chuteuse avec ou sans incontinence." Thèse, 2019. http://hdl.handle.net/1866/23620.
Aims: The fall rate in urinary incontinent (UI) older women is higher when compared that with continent women. One hypothesis is that a strong desire to void (SDV) could alter gait parameters and therefore increase the risk of falls. The aim of this study was to investigate and compare the effect of SDV on gait parameters in incontinent and continent older women who experienced falls. The secondary aim was to determine the relationship between UI severity and gait parameters in incontinent women. Methods: A quasi-experimental pilot study was conducted with two groups of healthy community-dwelling women who experienced at least one fall in the last year: continent (n=17; age: 74.1 ± 4.3) and urgency UI and mixed UI women (n=15; age: 73.5 ± 5.9). We recorded, analyzed and compared spatiotemporal gait parameters for participants in each group with both SDV and no desire to void condition. Results: Reduced velocity (p=0.05) and stride width (p=0.02) were observed in both groups with SDV. An increased incontinence severity was correlated with reduced velocity (rs=-0.56, p=0.03) and increased stride length variability (rs=0.54, p=0.04) in SDV condition. An increased incontinence severity was correlated with reduced velocity (rs=-0.63, p=0.01), increased stance time (rs=0.65, p=0.01) and stance time variability (rs=0.65, p=0.01) in no desire to void condition. Conclusions: SDV alter gait parameters regardless of continence status. Further, UI severity was correlated to gait parameters that constitute a risk of falling.
Book chapters on the topic "Incontinence urinaire – thérapie":
Baron, M., and J. N. Cornu. "Thérapie cellulaire et autres techniques émergentes dans le traitement de l'incontinence urinaire féminine." In Incontinence Urinaire Féminine, 175–78. Elsevier, 2017. http://dx.doi.org/10.1016/b978-2-294-75732-7.00026-1.
Jousse, M. "Thérapies comportementales et cognitives pour une incontinence urinaire féminine." In Incontinence Urinaire Féminine, 107–10. Elsevier, 2017. http://dx.doi.org/10.1016/b978-2-294-75732-7.00016-9.